• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
276.1595271
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
92.11
8790.91
EPS(TTM)
Face Value()
Div & Yield %
9.76
1
0.11
 

Hardwyn India Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015
Jun 07,2025
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of Hardwyn India Limited held on Saturday 07 June 2025 at the Registered Office of the Company situated at B-101 Phase-1 Mayapuri New Delhi South West Delhi Delhi 110064 India to considered and approved the following matters(s): 1. Audited Financial Results (Standalone) of the Company for the quarter and Financial Year ended 31st March 2025. 2. Audited Financial Results (Consolidated) of the Company for the quarter and Financial Year ended 31st March 2025.